UPDATE: The number of people suffering from type 2 diabetes in Hunter New England has soared to approximately 90,000, prompting an urgent call for enhanced technological interventions to combat this escalating crisis. This alarming statistic reflects the growing impact of the “diabesity epidemic,” which is now affecting nearly one in eight individuals in the region.
Officials confirm that thousands more are likely living with undiagnosed and untreated diabetes, exacerbating a health crisis that is now seen as “the biggest epidemic in human history.” Professor Sham Acharya from the Hunter Medical Research Institute (HMRI) emphasized the pressing nature of this issue, stating, “It adds a lot to hospitalizations and costs to society.”
In a proactive response, a type 2 diabetes education event is scheduled for Friday, November 10, at HMRI to coincide with World Diabetes Day. Hosted by the Diabetes Alliance Program Plus, this event aims to equip health professionals with the latest advancements in diabetes management and technology. Notable speaker Laureate Professor Clare Collins from the University of Newcastle will focus on improving access to “evidence-based nutrition assessments and advice” through innovative telehealth solutions.
Diabetes-related complications are severe, including heart disease, kidney issues, blindness, and amputations. In Hunter New England, approximately 1,300 to 1,500 hospitalizations occur annually due to type 2 diabetes, along with 250 amputations and 550 deaths linked to the condition.
Professor Acharya highlighted that approximately 65 percent of type 2 diabetes cases are driven by obesity, while another 30 to 35 percent are attributed to genetic factors, medications, and aging. He noted, “As we get older, our risk of diabetes goes up exponentially,” particularly impacting disadvantaged and First Nations communities.
The diabetes crisis has led to a significant burden on the healthcare system, with hospitalizations related to type 2 diabetes accounting for around 20 percent of total hospital admissions in the region. As highlighted by Professor Acharya, “We are understaffed, and the healthcare system is underprepared to face diabetes.” He called for increased resources, including more primary care staff and specialists, to effectively manage the rising numbers.
Excitingly, new weight loss medications such as Ozempic, Wegovy, and Mounjaro show promise in preventing the progression from prediabetes to diabetes, boasting about 95 percent effectiveness when used appropriately. However, the cost of these medications remains a significant barrier.
Looking ahead, Professor Acharya urged communities to prioritize diabetes prevention through lifestyle changes: “Everyone should try to optimize their weight, exercise, eat nutritiously, and get checked regularly.” He emphasized that discussions with GPs about preventative medications could also play a crucial role in combating this epidemic.
As the situation develops, the upcoming event at HMRI is critical for healthcare professionals and community members alike. It represents a concerted effort to address the urgent diabetes crisis plaguing Hunter New England and beyond. Stay tuned for updates as this situation evolves.
